Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali
Clinical trial NCT02535767 · COMPLETED
Trial details
- NCT number
- NCT02535767
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-01-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.